(Q38292980)

English

Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor (English)

1 reference

Europe PubMed Central

1 September 2017

1

object named as

Donald F Smee

1 reference

Europe PubMed Central

1 September 2017

Larisa Gubareva

8

object named as

Larisa V Gubareva

1 reference

Europe PubMed Central

1 September 2017

Vasiliy P Mishin

7

object named as

Vasiliy P Mishin

1 reference

Europe PubMed Central

1 September 2017

Barry R O'Keefe

4

object named as

Barry R O'Keefe

1 reference

Europe PubMed Central

1 September 2017

author name string

Miles K Wandersee

2

1 reference

Europe PubMed Central

1 September 2017

Melissa B Checketts

3

1 reference

Europe PubMed Central

1 September 2017

Carrie Saucedo

5

1 reference

Europe PubMed Central

1 September 2017

Michael R Boyd

6

1 reference

Europe PubMed Central

1 September 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

1 September 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

1 September 2017

18

1 reference

Europe PubMed Central

1 September 2017

6

1 reference

Europe PubMed Central

1 September 2017

317-327

1 reference

Europe PubMed Central

1 September 2017

Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice.

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800604

21 January 2018

Identifiers

10.1177/095632020701800604

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38292980&oldid=1972784977"